ReviewCells2026
New and Emerging Research Models for Sepsis.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The central role of mitochondrial pathology in sepsis-induced cardiomyopathy: from molecular mechanisms to clinical translation.Frontiers in cardiovascular medicine · 2026Review
- Crosstalk between innate immune signaling pathways and integrated TLR, NLRP3 inflammasome, cGAS-STING, and NF-κB networks in sepsis.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Human sepsis is a complex disease that manifests with a diverse range of phenotypes and inherent variability among individuals, making it hard to develop a comprehensive animal model. Despite this difficulty, numerous animal models have been developed that capture many key aspects of human sepsis. Though the animal models have contributed to the fundamental advances in understanding the pathogenesis of septic patients, the translational value of these models has been constantly questioned because many clinical trials of targeted therapies based on the advances in animal models have failed, highlighting the urgent need for developing new research models or refining previous animal models for sepsis research. In this review, we will summarize recent advances in new and emerging research models for sepsis, including human-based in vitro systems, highly tailored animal models, AI and digital models analyzing vast datasets to define patient subgroups and predict outcomes, and the FAMOUS framework ensuring that therapies are tested against the specific mechanism they are designed to target. We will discuss the strengths and limitations of these models, reflecting the clinical course of sepsis, and discuss the future directions in this subject area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.